The cost of Glyxambi is influenced by several factors, including insurance coverage, pharmacy, and the quantity prescribed. Without insurance, a 30-day supply can range significantly. For example, a 30-day supply of Glyxambi (Empagliflozin and Linagliptin) tablets, 10mg/5mg, can cost around $500 to $600 at retail pharmacies [1].
How Can I Get Glyxambi for Less?
Patients may be able to reduce the out-of-pocket cost of Glyxambi through various programs. Manufacturer coupons and savings cards can often lower the price. For eligible individuals, these programs can bring the cost down to as little as $10 or $25 for a 30-day supply [1]. Checking the official Glyxambi website or consulting with a pharmacist can provide information on available savings programs [1].
What Insurance Plans Cover Glyxambi?
Glyxambi is covered by many commercial insurance plans. However, coverage details and patient costs can vary widely between different insurance providers and specific plan designs. It is advisable for individuals to verify their specific coverage with their insurance company or pharmacist.
When Does Glyxambi's Patent Expire?
Information regarding the patent expiry for Glyxambi can be found on specialized resources that track drug patents. For instance, DrugPatentWatch.com provides details on patents related to pharmaceuticals [2]. The exact expiration dates for patents associated with Glyxambi and its active ingredients, empagliflozin and linagliptin, would need to be consulted from such databases.
Can Generic Versions of Glyxambi Be Made?
The development and availability of generic versions of Glyxambi depend on the expiration of relevant patents and any associated exclusivity periods. Once patents expire, and if regulatory hurdles are cleared, generic manufacturers can produce and market their own versions of the drug, which typically leads to lower prices.
What are the Benefits of Glyxambi?
Glyxambi is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It combines two oral antidiabetic agents: empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, and linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor [3].
What Are the Risks and Side Effects of Glyxambi?
Like all medications, Glyxambi can cause side effects. Common side effects may include urinary tract infections, stuffy or runny nose, cough, diarrhea, and a headache [3]. Serious side effects can include pancreatitis, low blood sugar (hypoglycemia), severe allergic reactions, and kidney problems. Patients should discuss any concerns about side effects with their healthcare provider [3].
How Does Glyxambi Work?
Glyxambi works through a dual mechanism. Empagliflozin works by blocking the reabsorption of glucose in the kidneys, leading to more glucose being excreted in the urine [3]. Linagliptin works by increasing the levels of incretin hormones, which help to regulate blood sugar by increasing insulin secretion and decreasing glucagon secretion from the pancreas [3].
Who Makes Glyxambi?
Glyxambi is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. [3].
---
Sources
1. https://www.goodrx.com/glyxambi
2. https://drugpatentwatch.com/
3. https://www.glyxambi.com/